In the last five years, there have been published novelties related to the management (e.g., diagnosis, drug treatment, minimally invasive interventional or surgical treatment) of renal vascular diseases or their consequences (e.g., arterial hypertension). In this volume we have added a chapter on the usefulness of knowledge of anatomy and anatomical variants in endovascular therapies or renal transplantation. We also presented an updated approach on paraclinical diagnostic techniques of the various renal vessels pathologies.

This book offers current protocols for treating renal artery or vein thrombosis, using (or not) combinations of the new antithrombotics.

As new data emerged concerning percutaneous interventions for renal artery stenosis, we comprehensively analyze published clinical trials to highlight the role of transcatheter renal artery stenting in contemporary cohorts of patients.

Given the recent news regarding theupdated techniques and the evidence supporting the indications of renal denervation in resistant hypertension, this volume dedicates three chapters to the new devices, indications from 2023, and extra-hypertensive uses of RDN.

In the last five years, there have been published novelties related to the management (e.g., diagnosis, drug treatment, minimally invasive interventional or surgical treatment) of renal vascular diseases or their consequences (e.g., arterial hypertension). In this volume we have added a chapter on the usefulness of knowledge of anatomy and anatomical variants in endovascular therapies or renal transplantation. We also presented an updated approach on paraclinical diagnostic techniques of the various renal vessels pathologies.

This book offers current protocols for treating renal artery or vein thrombosis, using (or not) combinations of the new antithrombotics.

As new data emerged concerning percutaneous interventions for renal artery stenosis, we comprehensively analyze published clinical trials to highlight the role of transcatheter renal artery stenting in contemporary cohorts of patients.

Given the recent news regarding theupdated techniques and the evidence supporting the indications of renal denervation in resistant hypertension, this volume dedicates three chapters to the new devices, indications from 2023, and extra-hypertensive uses of RDN.